Genmab A/S Updates Articles of Association and Share Capital Authorizations

Genmab A/S filed a Form 6-K on June 17, 2026, to provide an English translation of its updated Articles of Association as of June 16, 2026. The filing outlines the company's corporate governance structure, including its share capital of DKK 62,353,252 and various authorizations granted to the Board of Directors. Key provisions include the Board's authority to increase share capital by up to DKK 6,600,000 until March 2029 and the power to issue warrants and convertible debt instruments. The articles also detail the process for general meetings, which can be held virtually under special circumstances, and the composition of the Board of Directors, which includes employee-elected members. Additionally, the filing describes an indemnification scheme for Board members, secondary to D&O insurance, effective until March 2029. Schedule A provides a detailed history of warrant issuances, re-issuances, and exercises under various authorizations dating back to 2014, reflecting the company's ongoing use of equity-based incentives for employees and management.